MARKET

ASCLF

ASCLF

Ascletis Pharma
OTCPK
0.720
NaN%
Closed 09:30 10/30 EDT
OPEN
--
PREV CLOSE
0.720
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
2.400
52 WEEK LOW
0.720
MARKET CAP
757.59M
P/E (TTM)
-8.3624
1D
5D
1M
3M
1Y
5Y
1D
Sagimet closes down after acne drug denifanstat data, closing of stock offering
Seeking Alpha · 10/01 21:41
Centessa is the top performing foreign healthcare stock YTD
Seeking Alpha · 04/08 21:43
Sagimet down as Chinese partner posts late-stage trial data for acne therapy
Seeking Alpha · 01/29 13:17
About ASCLF
Ascletis Pharma Inc is an investment holding company mainly engaged in the research and development, production, and sales of pharmaceutical products. The Company focuses on viral diseases, non-alcoholic steatohepatitis (NASH) or primary biliary cholangitis (PBC), and oncology. The Company's product pipeline includes ASC22 for chronic hepatitis B functional cure, ASC10 for respiratory syncytial virus (RSV), ASC22 for human immunodeficiency virus (HIV) functional cure, ASC10 and ASC11 for COVID-19, ASC41 for NASH, ASC42 for PBC, ASC61 for solid tumors, ASC40 for moderate and severe acne, and others. The Company conducts its business in the domestic and overseas markets.

Webull offers Ascletis Pharma Inc stock information, including OTCPK: ASCLF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASCLF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ASCLF stock methods without spending real money on the virtual paper trading platform.